General Information
Version
6.7
Revision date
2023-02-11
Product name
Thiocolchicoside
CAS No.
602-41-5
REACH No
is
Emergency telephone
+33 (0)9 75 18 14 07, +33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
Merck Life Science S.A.S
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H341, H361fd, H372
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H301 Toxic if swallowed. H341 Suspected of causing genetic defects. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H372 Causes damage to organs (Gastro-intestinal system) through prolonged or repeated exposure. Reduced Labeling (<= 125 ml) H341 Suspected of causing genetic defects. H372 Causes damage to organs through prolonged or repeated exposure. H301 Toxic if swallowed. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P201 Obtain special instructions before use. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.